85 results on '"Tommiska J"'
Search Results
2. Genetic Testing for Pulmonary Arterial Hypertension: Diagnostic Yield and Findings From a Cohort of Patients Referred for Targeted Panel Testing
- Author
-
Hathaway, J., primary, Zilliacus, E., additional, Cicerchia, M., additional, Tommiska, J., additional, Ahonen, S., additional, Seppälä, E., additional, Gall, K., additional, Scocchia, A., additional, Saarinen, I., additional, Rantanen, M., additional, Schleit, J., additional, Kangas-Kontio, T., additional, Gentile, M., additional, Salmenperä, P., additional, Paananen, J., additional, Myllykangas, S., additional, and Koskenvuo, J., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Diagnostic Yield of Panel Genetic Testing in a Cohort of >200 Patients With Congenital Heart Disease
- Author
-
Zilliacus, E., primary, Hathaway, J., additional, Cicerchia, M., additional, Tommiska, J., additional, Ahonen, S., additional, Seppälä, E., additional, Gall, K., additional, Scocchia, A., additional, Saarinen, I., additional, Rantanen, M., additional, Schleit, J., additional, Kangas-Kontio, T., additional, Gentile, M., additional, Salmenperä, P., additional, Paananen, J., additional, Myllykangas, S., additional, and Koskenvuo, J., additional
- Published
- 2022
- Full Text
- View/download PDF
4. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer
- Author
-
Tommiska, J, Bartkova, J, Heinonen, M, Hautala, L, Kilpivaara, O, Eerola, H, Aittomäki, K, Hofstetter, B, Lukas, J, von Smitten, K, Blomqvist, C, Ristimäki, A, Heikkilä, P, Bartek, J, and Nevanlinna, H
- Published
- 2008
- Full Text
- View/download PDF
5. Neuron-derived neurotrophic factor (NDNF) is mutated in patients with Congenital Hypogonadotropic Hypogonadism
- Author
-
Messina, A., Pulli, K., Santini, S., Acierno, J., Känsäkoski, J., Cassatella, D., Xu, C., Casoni, F., Malone, S. A., Ternier, G., Conte, D., Sidis, Y., Tommiska, J., Vaaralahti, K., Dwyer, A., Gothilf, Y., Merlo, G. R., Santoni, F., Niederländer, N. J., Giacobini, P., Raivio, T., and Pitteloud, N
- Subjects
Gonadotropin Kallmann Disease GnRH Animal Model of Disease Neurotrophic Factor - Published
- 2020
6. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism
- Author
-
Laitinen, E. M., Hero, M., Vaaralahti, K., Tommiska, J., and Raivio, T.
- Published
- 2012
- Full Text
- View/download PDF
7. No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer
- Author
-
Vahteristo, P, Ojala, S, Tamminen, A, Tommiska, J, Sammalkorpi, H, Kiuru-Kuhlefelt, S, Eerola, H, Aaltonen, L A, Aittomäki, K, and Nevanlinna, H
- Published
- 2005
8. Two missense mutations in KCNQ1 cause pituitary hormone deficiency and maternally inherited gingival fibromatosis
- Author
-
Tommiska, J. (Johanna), Känsäkoski, J. (Johanna), Skibsbye, L. (Lasse), Vaaralahti, K. (Kirsi), Liu, X. (Xiaonan), Lodge, E. J. (Emily J.), Tang, C. (Chuyi), Yuan, L. (Lei), Fagerholm, R. (Rainer), Kanters, J. K. (Jørgen K.), Lahermo, P. (Päivi), Kaunisto, M. (Mari), Keski-Filppula, R. (Riikka), Vuoristo, S. (Sanna), Pulli, K. (Kristiina), Ebeling, T. (Tapani), Valanne, L. (Leena), Sankila, E.-M. (Eeva-Marja), Kivirikko, S. (Sirpa), Lääperi, M. (Mitja), Casoni, F. (Filippo), Giacobini, P. (Paolo), Phan-Hug, F. (Franziska), Buki, T. (Tal), Tena-Sempere, M. (Manuel), Pitteloud, N. (Nelly), Veijola, R. (Riitta), Lipsanen-Nyman, M. (Marita), Kaunisto, K. (Kari), Mollard, P. (Patrice), Andoniadou, C. L. (Cynthia L.), Hirsch, J. A. (Joel A.), Varjosalo, M. (Markku), Jespersen, T. (Thomas), Raivio, T. (Taneli), Tommiska, J. (Johanna), Känsäkoski, J. (Johanna), Skibsbye, L. (Lasse), Vaaralahti, K. (Kirsi), Liu, X. (Xiaonan), Lodge, E. J. (Emily J.), Tang, C. (Chuyi), Yuan, L. (Lei), Fagerholm, R. (Rainer), Kanters, J. K. (Jørgen K.), Lahermo, P. (Päivi), Kaunisto, M. (Mari), Keski-Filppula, R. (Riikka), Vuoristo, S. (Sanna), Pulli, K. (Kristiina), Ebeling, T. (Tapani), Valanne, L. (Leena), Sankila, E.-M. (Eeva-Marja), Kivirikko, S. (Sirpa), Lääperi, M. (Mitja), Casoni, F. (Filippo), Giacobini, P. (Paolo), Phan-Hug, F. (Franziska), Buki, T. (Tal), Tena-Sempere, M. (Manuel), Pitteloud, N. (Nelly), Veijola, R. (Riitta), Lipsanen-Nyman, M. (Marita), Kaunisto, K. (Kari), Mollard, P. (Patrice), Andoniadou, C. L. (Cynthia L.), Hirsch, J. A. (Joel A.), Varjosalo, M. (Markku), Jespersen, T. (Thomas), and Raivio, T. (Taneli)
- Abstract
Familial growth hormone deficiency provides an opportunity to identify new genetic causes of short stature. Here we combine linkage analysis with whole-genome resequencing in patients with growth hormone deficiency and maternally inherited gingival fibromatosis. We report that patients from three unrelated families harbor either of two missense mutations, c.347G>T p.(Arg116Leu) or c.1106C>T p.(Pro369Leu), in KCNQ1, a gene previously implicated in the long QT interval syndrome. Kcnq1 is expressed in hypothalamic GHRH neurons and pituitary somatotropes. Co-expressing KCNQ1 with the KCNE2 β-subunit shows that both KCNQ1 mutants increase current levels in patch clamp analyses and are associated with reduced pituitary hormone secretion from AtT-20 cells. In conclusion, our results reveal a role for the KCNQ1 potassium channel in the regulation of human growth, and show that growth hormone deficiency associated with maternally inherited gingival fibromatosis is an allelic disorder with cardiac arrhythmia syndromes caused by KCNQ1 mutations.
- Published
- 2017
9. Characterization of two retinoschisis gene mutations: a noncontiguous two-part deletion and a deletion covering exons of three adjacent genes RS1, PPEF1, and STK9
- Author
-
Tyynismaa, H., Huopaniemi, L., Tommiska, J., Rantala, A., Rosenberg, T., and Alitalo, T.
- Subjects
Genetic research -- Analysis ,Human genetics -- Research ,Retinal diseases -- Genetic aspects ,Biological sciences - Published
- 2000
10. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia
- Author
-
Raivio, T, Avbelj, M, McCabe, MJ, Romero, CJ, Dwyer, AA, Tommiska, J, Sykiotis, GP, Gregory, LC, Diaczok, D, Tziaferi, V, Elting, MW, Padidela, R, Plummer, L, Martin, C, Feng, B, Zhang, C, Zhou, QY, Chen, H, Mohammadi, M, Quinton, R, Sidis, Y, Radovick, S, Dattani, MT, Pitteloud, N, Raivio, T, Avbelj, M, McCabe, MJ, Romero, CJ, Dwyer, AA, Tommiska, J, Sykiotis, GP, Gregory, LC, Diaczok, D, Tziaferi, V, Elting, MW, Padidela, R, Plummer, L, Martin, C, Feng, B, Zhang, C, Zhou, QY, Chen, H, Mohammadi, M, Quinton, R, Sidis, Y, Radovick, S, Dattani, MT, and Pitteloud, N
- Abstract
Context: Kallmann syndrome (KS), combined pituitary hormone deficiency (CPHD), and septo-optic dysplasia (SOD) all result from development defects of the anterior midline in the human forebrain. Objective: The objective of the study was to investigate whether KS, CPHD, and SOD have shared genetic origins. Design and Participants: A total of 103 patients with either CPHD (n = 35) or SOD (n = 68) were investigated for mutations in gene simplicated in the etiology of KS (FGFR1, FGF8, PROKR2, PROK2, and KAL1). Consequences of identified FGFR1, FGF8, and PROKR2 mutations were investigated in vitro. Results: Three patients with SOD had heterozygous mutations in FGFR1; these were either shown to alter receptor signaling (p.S450F, p.P483S) or predicted to affect splicing (c.336C>T, p.T112T). One patient had a synonymous change in FGF8 (c.216G>A, p.T72T) that was shown to affect splicing and ligand signaling activity. Four patients with CPHD/SOD were found to harbor heterozygous rare loss-of-function variants in PROKR2 (p.R85G, p.R85H, p.R268C). Conclusions: Mutations in FGFR1/FGF8/PROKR2 contributed to 7.8% of our patients with CPHD/ SOD. These data suggest a significant genetic overlap between conditions affecting the development of anterior midline in the human forebrain. Copyright © 2012 by The Endocrine Society.
- Published
- 2012
11. Hereditary myopathy with early respiratory failure: occurrence in various populations
- Author
-
Palmio, J., primary, Evila, A., additional, Chapon, F., additional, Tasca, G., additional, Xiang, F., additional, Bradvik, B., additional, Eymard, B., additional, Echaniz-Laguna, A., additional, Laporte, J., additional, Karppa, M., additional, Mahjneh, I., additional, Quinlivan, R., additional, Laforet, P., additional, Damian, M., additional, Berardo, A., additional, Taratuto, A. L., additional, Bueri, J. A., additional, Tommiska, J., additional, Raivio, T., additional, Tuerk, M., additional, Golitz, P., additional, Chevessier, F., additional, Sewry, C., additional, Norwood, F., additional, Hedberg, C., additional, Schroder, R., additional, Edstrom, L., additional, Oldfors, A., additional, Hackman, P., additional, and Udd, B., additional
- Published
- 2013
- Full Text
- View/download PDF
12. Genetic Overlap between Holoprosencephaly and Kallmann Syndrome
- Author
-
Vaaralahti, K., primary, Raivio, T., additional, Koivu, R., additional, Valanne, L., additional, Laitinen, E.-M., additional, and Tommiska, J., additional
- Published
- 2012
- Full Text
- View/download PDF
13. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer
- Author
-
Tommiska, J, primary, Bartkova, J, additional, Heinonen, M, additional, Hautala, L, additional, Kilpivaara, O, additional, Eerola, H, additional, Aittomäki, K, additional, Hofstetter, B, additional, Lukas, J, additional, von Smitten, K, additional, Blomqvist, C, additional, Ristimäki, A, additional, Heikkilä, P, additional, Bartek, J, additional, and Nevanlinna, H, additional
- Published
- 2007
- Full Text
- View/download PDF
14. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer
- Author
-
Pylkas, K., primary, Tommiska, J., additional, Syrjakoski, K., additional, Kere, J., additional, Gatei, M., additional, Waddell, N., additional, Allinen, M., additional, Karppinen, S.-M., additional, Rapakko, K., additional, Kaariainen, H., additional, Aittomaki, K., additional, Blomqvist, C., additional, Mustonen, A., additional, Holli, K., additional, Khanna, K. K., additional, Kallioniemi, O.-P., additional, Nevanlinna, H., additional, and Winqvist, R., additional
- Published
- 2006
- Full Text
- View/download PDF
15. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
- Author
-
Hero M, Tommiska J, Vaaralahti K, Laitinen EM, Sipilä I, Puhakka L, Dunkel L, and Raivio T
- Published
- 2012
- Full Text
- View/download PDF
16. Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations
- Author
-
Villanueva C, Jacobson-Dickman E, Xu C, ManouvrierS, DwyerA, Sykiotis GP, Beenken A, Liu Y, Tommiska J, Hu Y, Tiosano D, Gerard M, Leger J, Drouin-Garraud V, Lefebvre H, Polak M, Carel J, Phan-Hug F, Hauschild M, Raivio T, Bouloux P, Sidis Y, Mohammadi M, de Roux N, and Pitteloud N
- Abstract
Purpose:Congenital hypogonadotropic hypogonadism (CHH) and split hand/foot malformation (SHFM) are two rare genetic conditions. Here we report a clinical entity comprising the two.Methods:We identified patients with CHH and SHFM through international collaboration. Probands and available family members underwent phenotyping and screening for FGFR1 mutations. The impact of identified mutations was assessed by sequence and structure based predictions and/or functional assays.Results:We identified eight probands with CHH with (n = 3; Kallmann syndrome) or without anosmia (n = 5) and SHFM seven of whom (88) harbor FGFR1 mutations. Of these seven one individual is homozygous for p.V429E and six individuals are heterozygous for p.G348R p.G485R p.Q594 p.E670A p.V688L or p.L712P. All mutations were predicted by in silico analysis to cause loss of function. Probands with FGFR1 mutations have severe gonadotropin releasing hormone deficiency (absent puberty and/or cryptorchidism and/or micropenis). SHFM in both hands and feet was observed only in the patient with the homozygous p.V429E mutation; V429 maps to the fibroblast growth factor receptor substrate 2a binding domain of FGFR1 and functional studies of the p.V429E mutation demonstrated that it decreased recruitment and phosphorylation of fibroblast growth factor receptor substrate 2a to FGFR1 thereby resulting in reduced mitogen activated protein kinase signaling.Conclusion:FGFR1 should be prioritized for genetic testing in patients with CHH and SHFM because the likelihood of a mutation increases from 10 in the general CHH population to 88 in these patients.Genet Med advance online publication 13 November 2014Genetics in Medicine (2014); doi:10.1038/gim.2014.166.
- Full Text
- View/download PDF
17. LIN28B, LIN28A, KISS1, and KISS1R in idiopathic central precocious puberty
- Author
-
Koivu Rosanna, Aksglaede Lise, Sørensen Kaspar, Tommiska Johanna, Puhakka Lea, Juul Anders, and Raivio Taneli
- Subjects
LIN28B ,LIN28A ,KISS1 ,KISS1R ,idiopathic central precocious puberty ,timing of puberty ,Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Background Pubertal timing is a strongly heritable trait, but no single puberty gene has been identified. Thus, the genetic background of idiopathic central precocious puberty (ICPP) is poorly understood. Overall, the genetic modulation of pubertal onset most likely arises from the additive effect of multiple genes, but also monogenic causes of ICPP probably exist, as cases of familial ICPP have been reported. Mutations in KISS1 and KISSR, coding for kisspeptin and its receptor, involved in GnRH secretion and puberty onset, have been suggested causative for monogenic ICPP. Variation in LIN28B was associated with timing of puberty in genome-wide association (GWA) studies. LIN28B is a human ortholog of the gene that controls, through microRNAs, developmental timing in C. elegans. In addition, Lin28a transgenic mice manifest the puberty phenotypes identified in the human GWAS. Thus, both LIN28B and LIN28A may have a role in pubertal development and are good candidate genes for monogenic ICPP. Methods Thirty girls with ICPP were included in the study. ICPP was defined by pubertal onset before 8 yrs of age, and a pubertal LH response to GnRH testing. The coding regions of LIN28B, LIN28A, KISS1, and KISS1R were sequenced. The missense change in LIN28B was also screened in 132 control subjects. Results No rare variants were detected in KISS1 or KISS1R in the 30 subjects with ICPP. In LIN28B, one missense change, His199Arg, was found in one subject with ICPP. However, this variant was also detected in one of the 132 controls. No variation in LIN28A was found. Conclusions We did not find any evidence that mutations in LIN28B or LIN28A would underlie ICPP. In addition, we confirmed that mutations in KISS1 and KISS1R are not a common cause for ICPP.
- Published
- 2011
- Full Text
- View/download PDF
18. Incidence, Phenotypic Features and Molecular Genetics of Kallmann Syndrome in Finland
- Author
-
Tommiska Johanna, Vaaralahti Kirsi, Laitinen Eeva-Maria, Eklund Elina, Tervaniemi Mari, Valanne Leena, and Raivio Taneli
- Subjects
Medicine - Abstract
Abstract Background Kallmann syndrome (KS), comprised of congenital hypogonadotropic hypogonadism (HH) and anosmia, is a clinically and genetically heterogeneous disorder. Its exact incidence is currently unknown, and a mutation in one of the identified KS genes has only been found in ~30% of the patients. Methods Herein, we investigated epidemiological, clinical, and genetic features of KS in Finland. Results The minimal incidence estimate of KS in Finland was 1:48 000, with clear difference between males (1:30 000) and females (1:125 000) (p = 0.02). The reproductive phenotype of 30 probands (25 men; 5 women) ranged from severe HH to partial puberty. Comprehensive mutation analysis of all 7 known KS genes (KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, and WDR11) in these 30 well-phenotyped probands revealed mutations in KAL1 (3 men) and FGFR1 (all 5 women vs. 4/25 men), but not in other genes. Conclusions Our results suggest that Finnish KS men harbor mutations in gene(s) yet-to-be discovered with sex-dependent penetrance of the disease phenotype. In addition, some KS patients without CHD7 mutations display CHARGE-syndrome associated phenotypic features (e.g. ear or eye anomalies), possibly implying that, in addition to CHD7, there may be other genes associated with phenotypes ranging from KS to CHARGE.
- Published
- 2011
- Full Text
- View/download PDF
19. ATM variants and cancer risk in breast cancer patients from Southern Finland
- Author
-
Aittomäki Kristiina, Tamminen Anitta, Kristensen Vessela, Edvardsen Hege, Kilpivaara Outi, Jansen Laila, Tommiska Johanna, Blomqvist Carl, Børresen-Dale Anne-Lise, and Nevanlinna Heli
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Individuals heterozygous for germline ATM mutations have been reported to have an increased risk for breast cancer but the role for ATM genetic variants for breast cancer risk has remained unclear. Recently, a common ATM variant, ATMivs38 -8T>C in cis with the ATMex39 5557G>A (D1853N) variant, was suggested to associate with bilateral breast cancer among familial breast cancer patients from Northern Finland. We have here evaluated the 5557G>A and ivs38-8T>C variants in an extensive case-control association analysis. We also aimed to investigate whether there are other ATM mutations or variants contributing to breast cancer risk in our population. Methods Two common ATM variants, 5557G>A and ivs38-8T>C, previously suggested to associate with bilateral breast cancer, were genotyped in an extensive set of 786 familial and 884 unselected breast cancer cases as well as 708 healthy controls. We also screened the entire coding region and exon-intron boundaries of the ATM gene in 47 familial breast cancer patients and constructed haplotypes of the patients. The identified variants were also evaluated for increased breast cancer risk among additional breast cancer cases and controls. Results Neither of the two common variants, 5557G>A and ivs38-8T>C, nor any haplotype containing them, was significantly associated with breast cancer risk, bilateral breast cancer or multiple primary cancers in any of the patient groups or subgoups. Three rare missense alterations and one intronic change were each found in only one patient of over 250 familial patients studied and not among controls. The fourth missense alteration studied further was found with closely similar frequencies in over 600 familial cases and controls. Conclusion Altogether, our results suggest very minor effect, if any, of ATM genetic variants on familial breast cancer in Southern Finland. Our results do not support association of the 5557G>A or ivs38-8T>C variant with increased breast cancer risk or with bilateral breast cancer.
- Published
- 2006
- Full Text
- View/download PDF
20. Variants on the promoter region of PTEN affect breast cancer progression and patient survival.
- Author
-
Heikkinen T, Greco D, Pelttari LM, Tommiska J, Vahteristo P, Heikkilä P, Blomqvist C, Aittomäki K, Nevanlinna H, Heikkinen, Tuomas, Greco, Dario, Pelttari, Liisa M, Tommiska, Johanna, Vahteristo, Pia, Heikkilä, Päivi, Blomqvist, Carl, Aittomäki, Kristiina, and Nevanlinna, Heli
- Abstract
Introduction: The PTEN gene, a regulator of the phosphatidylinositol-3-kinase (PI3K)/Akt oncogenic pathway, is mutated in various cancers and its expression has been associated with tumor progression in a dose-dependent fashion. We investigated the effect of germline variation in the promoter region of the PTEN gene on clinical characteristics and survival in breast cancer.Methods: We screened the promoter region of the PTEN gene for germline variation in 330 familial breast cancer cases and further determined the genotypes of three detected PTEN promoter polymorphisms -903GA, -975GC, and -1026CA in a total of 2,412 breast cancer patients to evaluate the effects of the variants on tumor characteristics and disease outcome. We compared the gene expression profiles in breast cancers of 10 variant carriers and 10 matched non-carriers and performed further survival analyses based on the differentially expressed genes.Results: All three promoter variants associated with worse prognosis. The Cox's regression hazard ratio for 10-year breast cancer specific survival in multivariate analysis was 2.01 (95% CI 1.17 to 3.46) P = 0.0119, and for 5-year breast cancer death or distant metastasis free survival 1.79 (95% CI 1.03 to 3.11) P = 0.0381 for the variant carriers, indicating PTEN promoter variants as an independent prognostic factor. The breast tumors from the promoter variant carriers exhibited a similar gene expression signature of 160 differentially expressed genes compared to matched non-carrier tumors. The signature further stratified patients into two groups with different recurrence free survival in independent breast cancer gene expression data sets.Conclusions: Inherited variation in the PTEN promoter region affects the tumor progression and gene expression profile in breast cancer. Further studies are warranted to establish PTEN promoter variants as clinical markers for prognosis in breast cancer. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
21. Postmortem Genetic Testing Following Sudden Cardiac Death Using a Cardiomyopathy and Arrhythmia Next-Generation Sequencing Panel.
- Author
-
Zilliacus, E., Hathaway, J., Huusko, J., Cicerchia, M., Ahonen, S., Tommiska, J., Gall, K., Sluyters, A., Lewis, A., Liaquat, K., Partack, E., Howell, V., Dodge, W., Djupsjöbacka, J., Muona, M., Saarinen, I., Seppälä, E., Kangas-Kontio, T., Koskinen, L., and Salmenperä, P.
- Subjects
- *
CARDIAC arrest , *GENETIC testing , *NUCLEOTIDE sequencing , *ARRHYTHMIA , *CARDIOMYOPATHIES - Published
- 2024
- Full Text
- View/download PDF
22. A splice site variant in MADD affects hormone expression in pancreatic β cells and pituitary gonadotropes.
- Author
-
Pulli K, Saarimäki-Vire J, Ahonen P, Liu X, Ibrahim H, Chandra V, Santambrogio A, Wang Y, Vaaralahti K, Iivonen AP, Känsäkoski J, Tommiska J, Kemkem Y, Varjosalo M, Vuoristo S, Andoniadou CL, Otonkoski T, and Raivio T
- Subjects
- Humans, Animals, Mice, Male, Gonadotrophs metabolism, Female, RNA Splice Sites genetics, Cell Line, Insulin metabolism, Siblings, Exons genetics, rab3 GTP-Binding Proteins metabolism, rab3 GTP-Binding Proteins genetics, Hypogonadism genetics, Hypogonadism metabolism, Hypogonadism pathology, Insulin-Secreting Cells metabolism
- Abstract
MAPK activating death domain (MADD) is a multifunctional protein regulating small GTPases RAB3 and RAB27, MAPK signaling, and cell survival. Polymorphisms in the MADD locus are associated with glycemic traits, but patients with biallelic variants in MADD manifest a complex syndrome affecting nervous, endocrine, exocrine, and hematological systems. We identified a homozygous splice site variant in MADD in 2 siblings with developmental delay, diabetes, congenital hypogonadotropic hypogonadism, and growth hormone deficiency. This variant led to skipping of exon 30 and in-frame deletion of 36 amino acids. To elucidate how this mutation causes pleiotropic endocrine phenotypes, we generated relevant cellular models with deletion of MADD exon 30 (dex30). We observed reduced numbers of β cells, decreased insulin content, and increased proinsulin-to-insulin ratio in dex30 human embryonic stem cell-derived pancreatic islets. Concordantly, dex30 led to decreased insulin expression in human β cell line EndoC-βH1. Furthermore, dex30 resulted in decreased luteinizing hormone expression in mouse pituitary gonadotrope cell line LβT2 but did not affect ontogeny of stem cell-derived GnRH neurons. Protein-protein interactions of wild-type and dex30 MADD revealed changes affecting multiple signaling pathways, while the GDP/GTP exchange activity of dex30 MADD remained intact. Our results suggest MADD-specific processes regulate hormone expression in pancreatic β cells and pituitary gonadotropes.
- Published
- 2024
- Full Text
- View/download PDF
23. Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients.
- Author
-
Heliö K, Cicerchia M, Hathaway J, Tommiska J, Huusko J, Saarinen I, Koskinen L, Muona M, Kytölä V, Djupsjöbacka J, Gentile M, Salmenperä P, Alastalo TP, Steinberg C, Heliö T, Paananen J, Myllykangas S, and Koskenvuo J
- Abstract
Background: Familial dilated cardiomyopathy (DCM) causes heart failure and may lead to heart transplantation. DCM is typically a monogenic disorder with autosomal dominant inheritance. Currently disease-causing variants have been reported in over 60 genes that encode proteins in sarcomeres, nuclear lamina, desmosomes, cytoskeleton, and mitochondria. Over half of the patients undergoing comprehensive genetic testing are left without a molecular diagnosis even when patient selection follows strict DCM criteria., Methods and Results: This study was a retrospective review of patients referred for genetic testing at Blueprint Genetics due to suspected inherited DCM. Next generation sequencing panels included 23-316 genes associated with cardiomyopathies and other monogenic cardiac diseases. Variants were considered diagnostic if classified as pathogenic (P) or likely pathogenic (LP). Of the 2,088 patients 514 (24.6%) obtained a molecular diagnosis; 534 LP/P variants were observed across 45 genes, 2.7% (14/514) had two diagnostic variants in dominant genes. Nine copy number variants were identified: two multigene and seven intragenic. Diagnostic variants were observed most often in TTN (45.3%), DSP (6.7%), LMNA (6.7%), and MYH7 (5.2%). Clinical characteristics independently associated with molecular diagnosis were: a lower age at diagnosis, family history of DCM, paroxysmal atrial fibrillation, absence of left bundle branch block, and the presence of an implantable cardioverter-defibrillator., Conclusions: Panel testing provides good diagnostic yield in patients with clinically suspected DCM. Causative variants were identified in 45 genes. In minority, two diagnostic variants were observed in dominant genes. Our results support the use of genetic panels in clinical settings in DCM patients with suspected genetic etiology., Competing Interests: MC, JH, JT, JH, IS, LK, MM, VK, JD, MG, PS, T-PA, JP, SM and JK are full-time employees of Blueprint Genetics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (© 2023 Heliö, Cicerchia, Hathaway, Tommiska, Huusko, Saarinen, Koskinen, Muona, Kytölä, Djupsjöbacka, Gentile, Salmenperä, Alastalo, Steinberg, Heliö, Paananen, Myllykangas and Koskenvuo.)
- Published
- 2023
- Full Text
- View/download PDF
24. GRINL1A Complex Transcription Unit Containing GCOM1, MYZAP, and POLR2M Genes Associates with Fully Penetrant Recessive Dilated Cardiomyopathy.
- Author
-
Heliö K, Mäyränpää MI, Saarinen I, Ahonen S, Junnila H, Tommiska J, Weckström S, Holmström M, Toivonen M, Nikus K, Hathaway J, Siivonen P, Muona M, Sistonen J, Salmenperä P, Gentile M, Paananen J, Myllykangas S, Alastalo TP, Heliö T, and Koskenvuo J
- Abstract
Background: Familial dilated cardiomyopathy (DCM) is a monogenic disorder typically inherited in an autosomal dominant pattern. We have identified two Finnish families with familial cardiomyopathy that is not explained by a variant in any previously known cardiomyopathy gene. We describe the cardiac phenotype related to homozygous truncating GCOM1 variants. Methods and Results: This study included two probands and their relatives. All the participants are of Finnish ethnicity. Whole-exome sequencing was used to test the probands; bi-directional Sanger sequencing was used to identify the GCOM1 variants in probands' family members. Clinical evaluation was performed, medical records and death certificates were obtained. Immunohistochemical analysis of myocardial samples was conducted. A homozygous GCOM1 variant was identified altogether in six individuals, all considered to be affected. None of the nine heterozygous family members fulfilled any cardiomyopathy criteria. Heart failure was the leading clinical feature, and the patients may have had a tendency for atrial arrhythmias. Conclusions: This study demonstrates the significance of GCOM1 variants as a cause of human cardiomyopathy and highlights the importance of searching for new candidate genes when targeted gene panels do not yield a positive outcome., Competing Interests: Authors IS, SA, HJ, JT, MT, JH, PS, MMU, JS, PS, MG, JP, SM, T-PA, and JK were employed by the company Blueprint Genetics, A Quest Diagnostics Company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Heliö, Mäyränpää, Saarinen, Ahonen, Junnila, Tommiska, Weckström, Holmström, Toivonen, Nikus, Hathaway, Siivonen, Muona, Sistonen, Salmenperä, Gentile, Paananen, Myllykangas, Alastalo, Heliö and Koskenvuo.)
- Published
- 2021
- Full Text
- View/download PDF
25. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
- Author
-
Hathaway J, Heliö K, Saarinen I, Tallila J, Seppälä EH, Tuupanen S, Turpeinen H, Kangas-Kontio T, Schleit J, Tommiska J, Kytölä V, Valori M, Muona M, Sistonen J, Gentile M, Salmenperä P, Myllykangas S, Paananen J, Alastalo TP, Heliö T, and Koskenvuo J
- Subjects
- Adolescent, Adult, Cardiomyopathy, Hypertrophic genetics, Cardiomyopathy, Hypertrophic physiopathology, Child, Child, Preschool, Female, Genetic Markers, Genetic Predisposition to Disease, Humans, Infant, Male, Phenotype, Predictive Value of Tests, Retrospective Studies, Risk Assessment, Risk Factors, Young Adult, Cardiomyopathy, Hypertrophic diagnosis, Genetic Testing, Genetic Variation
- Abstract
Background: Genetic testing in hypertrophic cardiomyopathy (HCM) is a published guideline-based recommendation. The diagnostic yield of genetic testing and corresponding HCM-associated genes have been largely documented by single center studies and carefully selected patient cohorts. Our goal was to evaluate the diagnostic yield of genetic testing in a heterogeneous cohort of patients with a clinical suspicion of HCM, referred for genetic testing from multiple centers around the world., Methods: A retrospective review of patients with a suspected clinical diagnosis of HCM referred for genetic testing at Blueprint Genetics was undertaken. The analysis included syndromic, myopathic and metabolic etiologies. Genetic test results and variant classifications were extracted from the database. Variants classified as pathogenic (P) or likely pathogenic (LP) were considered diagnostic., Results: A total of 1376 samples were analyzed. Three hundred and sixty-nine tests were diagnostic (26.8%); 373 P or LP variants were identified. Only one copy number variant was identified. The majority of diagnostic variants involved genes encoding the sarcomere (85.0%) followed by 4.3% of diagnostic variants identified in the RASopathy genes. Two percent of diagnostic variants were in genes associated with a cardiomyopathy other than HCM or an inherited arrhythmia. Clinical variables that increased the likelihood of identifying a diagnostic variant included: an earlier age at diagnosis (p < 0.0001), a higher maximum wall thickness (MWT) (p < 0.0001), a positive family history (p < 0.0001), the absence of hypertension (p = 0.0002), and the presence of an implantable cardioverter-defibrillator (ICD) (p = 0.0004)., Conclusion: The diagnostic yield of genetic testing in this heterogeneous cohort of patients with a clinical suspicion of HCM is lower than what has been reported in well-characterized patient cohorts. We report the highest yield of diagnostic variants in the RASopathy genes identified in a laboratory cohort of HCM patients to date. The spectrum of genes implicated in this unselected cohort highlights the importance of pre-and post-test counseling when offering genetic testing to the broad HCM population.
- Published
- 2021
- Full Text
- View/download PDF
26. Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy.
- Author
-
Koskenvuo JW, Saarinen I, Ahonen S, Tommiska J, Weckström S, Seppälä EH, Tuupanen S, Kangas-Kontio T, Schleit J, Heliö K, Hathaway J, Gummesson A, Dahlberg P, Ojala TH, Vepsäläinen V, Kytölä V, Muona M, Sistonen J, Salmenperä P, Gentile M, Paananen J, Myllykangas S, Alastalo TP, and Heliö T
- Subjects
- Adult, Child, Preschool, Female, Genetic Testing, Humans, Loss of Function Mutation, Male, Middle Aged, Retrospective Studies, Young Adult, Cardiomyopathy, Dilated diagnosis, Cardiomyopathy, Dilated genetics, Muscle Proteins genetics
- Abstract
Background: Familial dilated cardiomyopathy (DCM) is typically a monogenic disorder with dominant inheritance. Although over 40 genes have been linked to DCM, more than half of the patients undergoing comprehensive genetic testing are left without molecular diagnosis. Recently, biallelic protein-truncating variants (PTVs) in the nebulin-related anchoring protein gene (NRAP) were identified in a few patients with sporadic DCM., Methods and Results: We determined the frequency of rare NRAP variants in a cohort of DCM patients and control patients to further evaluate role of this gene in cardiomyopathies. A retrospective analysis of our internal variant database consisting of 31,639 individuals who underwent genetic testing (either panel or direct exome sequencing) was performed. The DCM group included 577 patients with either a confirmed or suspected DCM diagnosis. A control cohort of 31,062 individuals, including 25,912 individuals with non-cardiac (control group) and 5,150 with non-DCM cardiac indications (Non-DCM cardiac group). Biallelic (n = 6) or two (n = 5) NRAP variants (two PTVs or PTV+missense) were identified in 11 unrelated probands with DCM (1.9%) but none of the controls. None of the 11 probands had an alternative molecular diagnosis. Family member testing supports co-segregation. Biallelic or potentially biallelic NRAP variants were enriched in DCM vs. controls (OR 1052, p<0.0001). Based on the frequency of NRAP PTVs in the gnomAD reference population, and predicting full penetrance, biallelic NRAP variants could explain 0.25%-2.46% of all DCM cases., Conclusion: Loss-of-function in NRAP is a cause for autosomal recessive dilated cardiomyopathy, supporting its inclusion in comprehensive genetic testing., Competing Interests: Drs. Koskenvuo, Saarinen, Ahonen, Tommiska, Seppälä, Tuupanen, Kangas-Kontio, Schleit, Hathaway, Kytölä, Muona, Sistonen, Salmenperä, Gentile, Paananen, Myllykangas, Alastalo are full-time employees of Blueprint Genetics, a Quest Diagnostics Company, which offers genetic diagnostics for cardiomyopathies. The funder provided support in the form of salaries for authors [JWK, IS, SA, JT, ST, TKK, JS, JH, VK, MM, JS, PS, MG, JP, SM, TPA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2021
- Full Text
- View/download PDF
27. Neuron-Derived Neurotrophic Factor Is Mutated in Congenital Hypogonadotropic Hypogonadism.
- Author
-
Messina A, Pulli K, Santini S, Acierno J, Känsäkoski J, Cassatella D, Xu C, Casoni F, Malone SA, Ternier G, Conte D, Sidis Y, Tommiska J, Vaaralahti K, Dwyer A, Gothilf Y, Merlo GR, Santoni F, Niederländer NJ, Giacobini P, Raivio T, and Pitteloud N
- Subjects
- Adolescent, Animals, Cohort Studies, Female, Heterozygote, Humans, Hypogonadism pathology, Male, Mice, Mice, Knockout, Nerve Growth Factors physiology, Neurons metabolism, Pedigree, Zebrafish, Cell Movement, Hypogonadism congenital, Hypogonadism genetics, Mutation, Nerve Growth Factors genetics, Neurons pathology
- Abstract
Congenital hypogonadotropic hypogonadism (CHH) is a rare genetic disorder characterized by infertility and the absence of puberty. Defects in GnRH neuron migration or altered GnRH secretion and/or action lead to a severe gonadotropin-releasing hormone (GnRH) deficiency. Given the close developmental association of GnRH neurons with the olfactory primary axons, CHH is often associated with anosmia or hyposmia, in which case it is defined as Kallmann syndrome (KS). The genetics of CHH are heterogeneous, and >40 genes are involved either alone or in combination. Several CHH-related genes controlling GnRH ontogeny encode proteins containing fibronectin-3 (FN3) domains, which are important for brain and neural development. Therefore, we hypothesized that defects in other FN3-superfamily genes would underlie CHH. Next-generation sequencing was performed for 240 CHH unrelated probands and filtered for rare, protein-truncating variants (PTVs) in FN3-superfamily genes. Compared to gnomAD controls the CHH cohort was statistically enriched for PTVs in neuron-derived neurotrophic factor (NDNF) (p = 1.40 × 10
-6 ). Three heterozygous PTVs (p.Lys62∗ , p.Tyr128Thrfs∗ 55, and p.Trp469∗ , all absent from the gnomAD database) and an additional heterozygous missense mutation (p.Thr201Ser) were found in four KS probands. Notably, NDNF is expressed along the GnRH neuron migratory route in both mouse embryos and human fetuses and enhances GnRH neuron migration. Further, knock down of the zebrafish ortholog of NDNF resulted in altered GnRH migration. Finally, mice lacking Ndnf showed delayed GnRH neuron migration and altered olfactory axonal projections to the olfactory bulb; both results are consistent with a role of NDNF in GnRH neuron development. Altogether, our results highlight NDNF as a gene involved in the GnRH neuron migration implicated in KS., (Copyright © 2019. Published by Elsevier Inc.)- Published
- 2020
- Full Text
- View/download PDF
28. Two missense mutations in KCNQ1 cause pituitary hormone deficiency and maternally inherited gingival fibromatosis.
- Author
-
Tommiska J, Känsäkoski J, Skibsbye L, Vaaralahti K, Liu X, Lodge EJ, Tang C, Yuan L, Fagerholm R, Kanters JK, Lahermo P, Kaunisto M, Keski-Filppula R, Vuoristo S, Pulli K, Ebeling T, Valanne L, Sankila EM, Kivirikko S, Lääperi M, Casoni F, Giacobini P, Phan-Hug F, Buki T, Tena-Sempere M, Pitteloud N, Veijola R, Lipsanen-Nyman M, Kaunisto K, Mollard P, Andoniadou CL, Hirsch JA, Varjosalo M, Jespersen T, and Raivio T
- Subjects
- Adolescent, Adrenocorticotropic Hormone metabolism, Adult, Alleles, Amino Acid Substitution, Animals, Arrhythmias, Cardiac genetics, Child, Child, Preschool, Female, Fibromatosis, Gingival metabolism, Humans, KCNQ1 Potassium Channel chemistry, KCNQ1 Potassium Channel metabolism, Male, Maternal Inheritance genetics, Mice, Middle Aged, Models, Molecular, Pedigree, Protein Interaction Maps, Recombinant Proteins chemistry, Recombinant Proteins genetics, Recombinant Proteins metabolism, Young Adult, Fibromatosis, Gingival genetics, Human Growth Hormone deficiency, KCNQ1 Potassium Channel genetics, Mutation, Missense
- Abstract
Familial growth hormone deficiency provides an opportunity to identify new genetic causes of short stature. Here we combine linkage analysis with whole-genome resequencing in patients with growth hormone deficiency and maternally inherited gingival fibromatosis. We report that patients from three unrelated families harbor either of two missense mutations, c.347G>T p.(Arg116Leu) or c.1106C>T p.(Pro369Leu), in KCNQ1, a gene previously implicated in the long QT interval syndrome. Kcnq1 is expressed in hypothalamic GHRH neurons and pituitary somatotropes. Co-expressing KCNQ1 with the KCNE2 β-subunit shows that both KCNQ1 mutants increase current levels in patch clamp analyses and are associated with reduced pituitary hormone secretion from AtT-20 cells. In conclusion, our results reveal a role for the KCNQ1 potassium channel in the regulation of human growth, and show that growth hormone deficiency associated with maternally inherited gingival fibromatosis is an allelic disorder with cardiac arrhythmia syndromes caused by KCNQ1 mutations.
- Published
- 2017
- Full Text
- View/download PDF
29. "Design for Somebody" - Approach Enabling Mobile Technology Development.
- Author
-
Sirkka A, Merilampi S, Koivisto A, Tommiska J, and Saarinen TP
- Subjects
- Humans, Disabled Persons, Industrial Development, Mobile Applications
- Abstract
This paper presents case examples of Design for Somebody (DfS) philosophy used both in developing novel technologies and modifying existing main stream technologies applicable for users with special needs. DfS embodies variety of mobile technology approaches to generate personalised means to enable and motivate physical, cognitive and social skills development.
- Published
- 2017
30. Complete androgen insensitivity syndrome caused by a deep intronic pseudoexon-activating mutation in the androgen receptor gene.
- Author
-
Känsäkoski J, Jääskeläinen J, Jääskeläinen T, Tommiska J, Saarinen L, Lehtonen R, Hautaniemi S, Frilander MJ, Palvimo JJ, Toppari J, and Raivio T
- Subjects
- Alternative Splicing, Androgen-Insensitivity Syndrome metabolism, Exons, Female, Genetic Predisposition to Disease, Humans, Introns, Male, Receptors, Androgen metabolism, Siblings, Exome Sequencing methods, Androgen-Insensitivity Syndrome genetics, Point Mutation, Receptors, Androgen genetics
- Abstract
Mutations in the X-linked androgen receptor (AR) gene underlie complete androgen insensitivity syndrome (CAIS), the most common cause of 46,XY sex reversal. Molecular genetic diagnosis of CAIS, however, remains uncertain in patients who show normal coding region of AR. Here, we describe a novel mechanism of AR disruption leading to CAIS in two 46,XY sisters. We analyzed whole-genome sequencing data of the patients for pathogenic variants outside the AR coding region. Patient fibroblasts from the genital area were used for AR cDNA analysis and protein quantification. Analysis of the cDNA revealed aberrant splicing of the mRNA caused by a deep intronic mutation (c.2450-118A>G) in the intron 6 of AR. The mutation creates a de novo 5' splice site and a putative exonic splicing enhancer motif, which leads to the preferential formation of two aberrantly spliced mRNAs (predicted to include a premature stop codon). Patient fibroblasts contained no detectable AR protein. Our results show that patients with CAIS and normal AR coding region need to be examined for deep intronic mutations that can lead to pseudoexon activation.
- Published
- 2016
- Full Text
- View/download PDF
31. Childhood growth in boys with congenital hypogonadotropic hypogonadism.
- Author
-
Varimo T, Hero M, Laitinen EM, Miettinen PJ, Tommiska J, Känsäkoski J, Juul A, and Raivio T
- Subjects
- Adolescent, Adolescent Development, Androgens deficiency, Child, Child Development, Child, Preschool, Denmark, Extracellular Matrix Proteins genetics, Finland, Gastrointestinal Hormones genetics, Genetic Association Studies, Humans, Infant, Infant, Newborn, Male, Nerve Tissue Proteins genetics, Neuropeptides genetics, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptors, LHRH genetics, Retrospective Studies, Hypogonadism physiopathology
- Abstract
Background: We describe childhood growth patterns in a series of well-characterized patients with congenital hypogonadotropic hypogonadism (CHH) with special emphasis on genotype-phenotype correlation., Methods: We retrospectively evaluated the growth charts of 36 males with CHH (27 from Finland and 9 from Denmark). Fifteen patients (42%) had representative growth measurements during the first year of life. Genetically verified diagnosis of CHH was made in 15 (42%) patients (KAL1, FGFR1, GNRHR, or PROK2)., Results: We found a deceleration of growth rate during early childhood. The mean (SD) length standard deviation score (SDS) at birth (0.2 (1.6) SDS) decreased significantly during the first 3 (to -0.9 (1.2) SDS) and 6 mo of life (to -0.7 (1.3) SDS). At the average age of 3 y, mean height SDS (-0.2 (1.3) SDS) did not differ from mid-parental target height (MPH). Mean height SDS reached its nadir (-1.7 (1.4) SDS) at an average age of 15.8 (0.8) years reflecting pubertal failure. Final heights did not differ from MPH. No clear genotype-growth associations emerged., Conclusion: Moderate postnatal length deflection is a novel feature of CHH and may reflect early androgen deficiency. Childhood growth patterns are not of clinical value in targeting molecular genetic diagnosis of CHH.
- Published
- 2016
- Full Text
- View/download PDF
32. Gonadotropin-releasing hormone receptor mutations in ageing men.
- Author
-
Tommiska J, Känsäkoski J, Pitteloud N, Wu F, and Raivio T
- Subjects
- Aged, DNA Mutational Analysis methods, Humans, Hypogonadism blood, Hypogonadism diagnosis, Male, Testosterone blood, Aging genetics, Genetic Predisposition to Disease genetics, Hypogonadism genetics, Mutation, Receptors, LHRH genetics
- Published
- 2016
- Full Text
- View/download PDF
33. A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty.
- Author
-
Känsäkoski J, Raivio T, Juul A, and Tommiska J
- Subjects
- Age Factors, Child, Computer Simulation, DNA Mutational Analysis, Denmark, Female, Genetic Predisposition to Disease, Gonadotropin-Releasing Hormone analogs & derivatives, Gonadotropin-Releasing Hormone therapeutic use, Heredity, Humans, Male, Models, Genetic, Pedigree, Phenotype, Puberty drug effects, Puberty, Precocious diagnosis, Puberty, Precocious drug therapy, Puberty, Precocious physiopathology, Risk Factors, Treatment Outcome, Ubiquitin-Protein Ligases, Fathers, Mutation, Missense, Puberty genetics, Puberty, Precocious genetics, Ribonucleoproteins genetics, Siblings
- Abstract
Background: Idiopathic central precocious puberty (ICPP) results from the premature reactivation of the hypothalamic-pituitary-gonadal axis leading to development of secondary sexual characteristics prior to 8 y in girls or 9 y in boys. Since the initial discovery of mutations in the maternally imprinted MKRN3 gene in 2013, several case reports have described mutations in this gene in ICPP patients from different populations, highlighting the importance of MKRN3 as a regulator of pubertal onset., Methods: We screened 29 Danish girls with ICPP for mutations in MKRN3. Expression of MKRN3 in human hypothalamic complementary DNA (cDNA) was investigated by PCR., Results: One paternally inherited rare variant, c.1034G>A (p.Arg345His), was identified in one girl with ICPP and in her brother with early puberty. The variant is predicted to be deleterious by three different in silico prediction programs. Expression of MKRN3 was confirmed in adult human hypothalamus., Conclusion: Our results are in line with previous studies in which paternally inherited MKRN3 mutations have been found both in males and in females with ICPP or early puberty. Our report further expands the set of MKRN3 mutations identified in ICPP patients across diverse populations, thus supporting the major regulatory function of MKRN3 in pubertal onset.
- Published
- 2015
- Full Text
- View/download PDF
34. Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations.
- Author
-
Villanueva C, Jacobson-Dickman E, Xu C, Manouvrier S, Dwyer AA, Sykiotis GP, Beenken A, Liu Y, Tommiska J, Hu Y, Tiosano D, Gerard M, Leger J, Drouin-Garraud V, Lefebvre H, Polak M, Carel JC, Phan-Hug F, Hauschild M, Plummer L, Rey JP, Raivio T, Bouloux P, Sidis Y, Mohammadi M, de Roux N, and Pitteloud N
- Subjects
- Adaptor Proteins, Signal Transducing metabolism, Amino Acid Sequence, Animals, Conserved Sequence, Female, Genetic Association Studies, Humans, Hypogonadism metabolism, Limb Deformities, Congenital metabolism, MAP Kinase Signaling System, Male, Membrane Proteins metabolism, Molecular Sequence Data, Pedigree, Phosphorylation, Receptor, Fibroblast Growth Factor, Type 1 metabolism, Hypogonadism congenital, Hypogonadism genetics, Limb Deformities, Congenital genetics, Mutation, Receptor, Fibroblast Growth Factor, Type 1 genetics
- Abstract
Purpose: Congenital hypogonadotropic hypogonadism (CHH) and split hand/foot malformation (SHFM) are two rare genetic conditions. Here we report a clinical entity comprising the two., Methods: We identified patients with CHH and SHFM through international collaboration. Probands and available family members underwent phenotyping and screening for FGFR1 mutations. The impact of identified mutations was assessed by sequence- and structure-based predictions and/or functional assays., Results: We identified eight probands with CHH with (n = 3; Kallmann syndrome) or without anosmia (n = 5) and SHFM, seven of whom (88%) harbor FGFR1 mutations. Of these seven, one individual is homozygous for p.V429E and six individuals are heterozygous for p.G348R, p.G485R, p.Q594*, p.E670A, p.V688L, or p.L712P. All mutations were predicted by in silico analysis to cause loss of function. Probands with FGFR1 mutations have severe gonadotropin-releasing hormone deficiency (absent puberty and/or cryptorchidism and/or micropenis). SHFM in both hands and feet was observed only in the patient with the homozygous p.V429E mutation; V429 maps to the fibroblast growth factor receptor substrate 2α binding domain of FGFR1, and functional studies of the p.V429E mutation demonstrated that it decreased recruitment and phosphorylation of fibroblast growth factor receptor substrate 2α to FGFR1, thereby resulting in reduced mitogen-activated protein kinase signaling., Conclusion: FGFR1 should be prioritized for genetic testing in patients with CHH and SHFM because the likelihood of a mutation increases from 10% in the general CHH population to 88% in these patients.
- Published
- 2015
- Full Text
- View/download PDF
35. Childhood growth of females with Kallmann syndrome and FGFR1 mutations.
- Author
-
Hero M, Laitinen EM, Varimo T, Vaaralahti K, Tommiska J, and Raivio T
- Subjects
- Adult, Early Diagnosis, Female, Humans, Kallmann Syndrome diagnosis, Kallmann Syndrome genetics, Phenotype, Retrospective Studies, Body Height genetics, Kallmann Syndrome physiopathology, Receptor, Fibroblast Growth Factor, Type 1 genetics
- Abstract
Objective: In search of phenotypic cues that would allow early detection of Kallmann syndrome (KS), we evaluated the paediatric phenotypes in a series of females with KS., Design, Patients and Measurements: In this retrospective cohort study, we investigated childhood growth in six females with KS due to mutations in FGFR1 and evaluated their reproductive phenotypes later in life., Results: While growth during early infancy and childhood was within normal limits, a decreasing trend in height SDS already from mid-childhood occurred in most patients. The lowest height SDS (mean, -1·2 SDS) occurred between 14 and 15 years of age, before the start of hormone replacement therapy. As adults, these women required assisted reproductive techniques for fertility. One of the probands passed on her G48S mutation to her son, who showed normal reproductive hormone levels during the minipuberty of infancy., Conclusions: Early diagnosis of female KS remains a challenge as early phenotypic signs, apart from anosmia, are scarce. Females with KS exhibit a slight reduction in growth rate during mid-childhood, but normal growth rate during the minipuberty of infancy, despite congenital lack of ovarian oestrogen. Women harbouring FGFR1 mutations will have 50% chance of passing on the gene defect to their offspring. We recommend genetic counselling to all females with KS to be carried out as a part of family planning., (© 2014 John Wiley & Sons Ltd.)
- Published
- 2015
- Full Text
- View/download PDF
36. De novo SOX10 nonsense mutation in a patient with Kallmann syndrome and hearing loss.
- Author
-
Vaaralahti K, Tommiska J, Tillmann V, Liivak N, Känsäkoski J, Laitinen EM, and Raivio T
- Subjects
- DNA Mutational Analysis, Exons, Humans, Male, Phenotype, Young Adult, Codon, Nonsense, Hearing Loss genetics, Kallmann Syndrome complications, Kallmann Syndrome genetics, SOXE Transcription Factors genetics
- Published
- 2014
- Full Text
- View/download PDF
37. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
- Author
-
Tommiska J, Känsäkoski J, Christiansen P, Jørgensen N, Lawaetz JG, Juul A, and Raivio T
- Subjects
- Denmark, Genetic Diseases, Inborn genetics, Humans, Male, Mutation, DNA Helicases genetics, DNA-Binding Proteins genetics, Extracellular Matrix Proteins genetics, Hypogonadism genetics, Nerve Tissue Proteins genetics, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptors, LHRH genetics
- Abstract
Congenital hypogonadotropic hypogonadism (CHH) is a rare disorder characterized by incomplete/absent puberty caused by deficiency or defective action of gonadotropin-releasing hormone (GnRH). The phenotypic features of patients with CHH vary from genital hypoplasia and absent puberty to reversal of HH later in life. We examined the genetics and clinical features of CHH in Denmark. Forty-one male patients were screened for mutations in KAL1, FGFR1, FGF8, PROK2, PROKR2, GNRHR, TAC3, TACR3, and KISS1R. CHD7 was screened in two patients with hearing loss. In 12 patients, a molecular genetic cause for CHH was found. Four patients had mutations in KAL1 (C105VfsX13, C53X, ex5-8del, R257X), and five in FGFR1 (G97S, R209C, A512V, R646W, and c.1614C>T, (p.I538I), predicted to affect splicing). All 9 had severe HH (cryptorchidism and/or micropenis), and 2 had cleft lip/palate. One patient with a previously reported homozygous R262Q mutation in GNRHR displayed fascinating temporal variation in his phenotype. Two patients with hearing loss had CHD7 mutations (c.7832_7841del (p.K2611MfsX25) and c.2443-2A>C), confirming that CHH patients with CHARGE syndrome-associated features should be screened for mutations in CHD7., (Copyright © 2014 Elsevier Masson SAS. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
38. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism.
- Author
-
Känsäkoski J, Fagerholm R, Laitinen EM, Vaaralahti K, Hackman P, Pitteloud N, Raivio T, and Tommiska J
- Subjects
- DNA Mutational Analysis, Female, Finland, GPI-Linked Proteins genetics, Genetic Variation, Gonadotropin-Releasing Hormone metabolism, Heterozygote, Humans, Male, Mutation, Mutation, Missense, Neurons metabolism, Phenotype, Antigens, CD genetics, Hypogonadism congenital, Hypogonadism genetics, Kallmann Syndrome genetics, Semaphorin-3A genetics, Semaphorins genetics
- Abstract
Background: Congenital hypogonadotropic hypogonadism (HH), a rare disorder characterized by absent, partial, or delayed puberty, can be caused by the lack or deficient number of hypothalamic gonadotropin-releasing hormone (GnRH) neurons. SEMA3A was recently implicated in the etiology of the disorder, and Sema7A-deficient mice have a reduced number of GnRH neurons in their brains., Methods: SEMA3A and SEMA7A were screened by Sanger sequencing in altogether 50 Finnish HH patients (34 with Kallmann syndrome (KS; HH with hyposmia/anosmia) and 16 with normosmic HH (nHH)). In 20 patients, mutation(s) had already been found in genes known to be implicated in congenital HH., Results: Three heterozygous variants (c.458A>G (p.Asn153Ser), c.1253A>G (p.Asn418Ser), and c.1303G>A (p.Val435Ile)) were found in SEMA3A in three KS patients, two of which also had a mutation in FGFR1. Two rare heterozygous variants (c.442C>T (p.Arg148Trp) and c.1421G>A (p.Arg474Gln)) in SEMA7A were found in one male nHH patient with a previously identified KISS1R nonsense variant and one male KS patient with a previously identified mutation in KAL1, respectively., Conclusion: Our results suggest that heterozygous missense variants in SEMA3A and SEMA7A may modify the phenotype of KS but most likely are not alone sufficient to cause the disorder.
- Published
- 2014
- Full Text
- View/download PDF
39. Hereditary myopathy with early respiratory failure: occurrence in various populations.
- Author
-
Palmio J, Evilä A, Chapon F, Tasca G, Xiang F, Brådvik B, Eymard B, Echaniz-Laguna A, Laporte J, Kärppä M, Mahjneh I, Quinlivan R, Laforêt P, Damian M, Berardo A, Taratuto AL, Bueri JA, Tommiska J, Raivio T, Tuerk M, Gölitz P, Chevessier F, Sewry C, Norwood F, Hedberg C, Schröder R, Edström L, Oldfors A, Hackman P, and Udd B
- Subjects
- Adult, Aged, Connectin genetics, Exome genetics, Female, Genetic Diseases, Inborn genetics, Genetic Diseases, Inborn pathology, Genetic Linkage genetics, Genetic Predisposition to Disease genetics, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Muscle, Skeletal pathology, Muscular Diseases genetics, Muscular Diseases pathology, Mutation genetics, Pedigree, Phenotype, Respiratory Insufficiency genetics, Respiratory Insufficiency pathology, Genetic Diseases, Inborn epidemiology, Muscular Diseases epidemiology, Respiratory Insufficiency epidemiology
- Abstract
Objective: Several families with characteristic features of hereditary myopathy with early respiratory failure (HMERF) have remained without genetic cause. This international study was initiated to clarify epidemiology and the genetic underlying cause in these families, and to characterise the phenotype in our large cohort., Methods: DNA samples of all currently known families with HMERF without molecular genetic cause were obtained from 12 families in seven different countries. Clinical, histopathological and muscle imaging data were collected and five biopsy samples made available for further immunohistochemical studies. Genotyping, exome sequencing and Sanger sequencing were used to identify and confirm sequence variations., Results: All patients with clinical diagnosis of HMERF were genetically solved by five different titin mutations identified. One mutation has been reported while four are novel, all located exclusively in the FN3 119 domain (A150) of A-band titin. One of the new mutations showed semirecessive inheritance pattern with subclinical myopathy in the heterozygous parents. Typical clinical features were respiratory failure at mid-adulthood in an ambulant patient with very variable degree of muscle weakness. Cytoplasmic bodies were retrospectively observed in all muscle biopsy samples and these were reactive for myofibrillar proteins but not for titin., Conclusions: We report an extensive collection of families with HMERF with five different mutations in exon 343 of TTN, which establishes this exon as the primary target for molecular diagnosis of HMERF. Our relatively large number of new families and mutations directly implies that HMERF is not extremely rare, not restricted to Northern Europe and should be considered in undetermined myogenic respiratory failure.
- Published
- 2014
- Full Text
- View/download PDF
40. PROKR2 mutations in autosomal recessive Kallmann syndrome.
- Author
-
Tommiska J, Toppari J, Vaaralahti K, Känsäkoski J, Laitinen EM, Noisa P, Kinnala A, Niinikoski H, and Raivio T
- Subjects
- Adolescent, Family Health, Female, Genotype, Humans, Male, Phenotype, Receptors, G-Protein-Coupled metabolism, Receptors, Peptide metabolism, Sertoli Cells physiology, Siblings, Signal Transduction genetics, Kallmann Syndrome genetics, Mutation, Missense, Receptors, G-Protein-Coupled genetics, Receptors, Peptide genetics
- Abstract
Objective: To investigate the inheritance pattern of two missense PROKR2 changes within a single family., Design: This is a descriptive study., Setting: Tertiary referral center., Patient(s): The proband and his brother, both with congenital hypogonadotropic hypogonadism and anosmia (Kallmann syndrome)., Intervention(s): Clinical and biochemical evaluation of Kallmann syndrome. Sequence analysis of the coding exons and exon-intron boundaries of KAL1, FGFR1, FGF8, PROK2, and PROKR2 from polymerase chain reaction (PCR)-amplified genomic DNA. Recombinant human FSH treatment of the proband., Main Outcome Measure(s): Phenotypic and genotypic features, and inhibin B response to recombinant human FSH., Result(s): The proband and his brother were homozygous for two variants in PROKR2; a novel mutation c.701G>A (p.G234D), and a polymorphism c.802C>T (p.R268C). Recombinant human FSH therapy of the proband increased serum inhibin B from <16 to 136 ng/L. The heterozygous parents were fertile and had six children., Conclusion(s): These findings are consistent with recessive mode of inheritance. PROKR2 signaling does not directly affect Sertoli cell function., (Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
41. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as reversal of hypogonadotropic hypogonadism and late-onset hypogonadism.
- Author
-
Tommiska J, Jørgensen N, Christiansen P, Juul A, and Raivio T
- Subjects
- Humans, Hypogonadism metabolism, Middle Aged, Mutation, Receptors, LHRH genetics, Hypogonadism genetics, Receptors, LHRH metabolism
- Published
- 2013
- Full Text
- View/download PDF
42. NQO1 expression correlates inversely with NFκB activation in human breast cancer.
- Author
-
Jamshidi M, Bartkova J, Greco D, Tommiska J, Fagerholm R, Aittomäki K, Mattson J, Villman K, Vrtel R, Lukas J, Heikkilä P, Blomqvist C, Bartek J, and Nevanlinna H
- Subjects
- Breast Neoplasms genetics, Breast Neoplasms mortality, Carcinoma, Ductal, Breast genetics, Carcinoma, Ductal, Breast mortality, Carcinoma, Lobular genetics, Carcinoma, Lobular mortality, Cell Nucleus metabolism, Female, Gene Expression Profiling, Humans, NAD(P)H Dehydrogenase (Quinone) genetics, Oligonucleotide Array Sequence Analysis, Proportional Hazards Models, Regression Analysis, Breast Neoplasms metabolism, Carcinoma, Ductal, Breast metabolism, Carcinoma, Lobular metabolism, NAD(P)H Dehydrogenase (Quinone) metabolism, NF-kappa B metabolism
- Abstract
NQO1 participates in cellular defense against oxidative stress and regulates apoptosis via p53- and NFκB-mediated pathways. We have previously found that homozygous missense variant NQO1*2 (rs1800566) predicts poor survival among breast cancer patients, particularly after anthracycline-based adjuvant chemotherapy. Here, we investigated NQO1 and NFκB protein expression and global gene expression profiles in breast tumors with correlation to tumor characteristics and survival after adjuvant chemotherapy. We used immunohistochemical analysis of tissue microarrays to study NQO1 and NFκB expression in two series of tumors: 1000 breast tumors unselected for treatment and 113 from a clinical trial comparing chemotherapy regimens after anthracycline treatment in advanced breast cancer. We used gene expression arrays to define genes co-expressed with NQO1 and NFκB. NQO1 and nuclear NFκB were expressed in 83% and 11% of breast tumors, and correlated inversely (P = 0.012). NQO1 protein expression was associated with estrogen receptor (ER) expression (P = 0.011), whereas 34.5% of NFκB-nuclear/activated tumors were ER negative (P = 0.001). NQO1 protein expression and NFκB activation showed only trends, but no statistical significance for patient survival or outcome after anthracycline treatment. Gene expression analysis highlighted 193 genes that significantly correlated with both NQO1 and NFκB in opposite directions, consistent with the expression patterns of the two proteins. Inverse correlation was found with genes related to oxidation/reduction, lipid biosynthesis and steroid metabolism, immune response, lymphocyte activation, Jak-STAT signaling and apoptosis. The inverse relationship between NQO1 protein expression and NFκB activation, underlined also by inverse patterns of association with ER and gene expression profiles of tumors, suggests that NQO1-NFκB interaction in breast cancer is different from several other tissue types, possibly due to estrogen receptor signaling in breast cancer. Neither NQO1 nor NFκB protein expression appear as significant prognostic or predictive markers in breast cancer.
- Published
- 2012
- Full Text
- View/download PDF
43. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
- Author
-
Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V, Elting MW, Padidela R, Plummer L, Martin C, Feng B, Zhang C, Zhou QY, Chen H, Mohammadi M, Quinton R, Sidis Y, Radovick S, Dattani MT, and Pitteloud N
- Subjects
- Animals, Female, Fibroblast Growth Factor 8 metabolism, Genetic Association Studies, Heterozygote, Humans, Hypopituitarism metabolism, Kallmann Syndrome metabolism, Male, Mice, Mice, Transgenic, Nerve Tissue Proteins genetics, Nerve Tissue Proteins metabolism, Neurons metabolism, Neurons pathology, Pituitary Gland, Posterior metabolism, Pituitary Gland, Posterior pathology, Receptors, G-Protein-Coupled metabolism, Receptors, Peptide metabolism, Recombinant Fusion Proteins metabolism, Septo-Optic Dysplasia metabolism, Signal Transduction, United Kingdom, United States, Fibroblast Growth Factor 8 genetics, Hypopituitarism genetics, Kallmann Syndrome genetics, Mutation, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptors, G-Protein-Coupled genetics, Receptors, Peptide genetics, Septo-Optic Dysplasia genetics
- Abstract
Context: Kallmann syndrome (KS), combined pituitary hormone deficiency (CPHD), and septo-optic dysplasia (SOD) all result from development defects of the anterior midline in the human forebrain., Objective: The objective of the study was to investigate whether KS, CPHD, and SOD have shared genetic origins., Design and Participants: A total of 103 patients with either CPHD (n = 35) or SOD (n = 68) were investigated for mutations in genes implicated in the etiology of KS (FGFR1, FGF8, PROKR2, PROK2, and KAL1). Consequences of identified FGFR1, FGF8, and PROKR2 mutations were investigated in vitro., Results: Three patients with SOD had heterozygous mutations in FGFR1; these were either shown to alter receptor signaling (p.S450F, p.P483S) or predicted to affect splicing (c.336C>T, p.T112T). One patient had a synonymous change in FGF8 (c.216G>A, p.T72T) that was shown to affect splicing and ligand signaling activity. Four patients with CPHD/SOD were found to harbor heterozygous rare loss-of-function variants in PROKR2 (p.R85G, p.R85H, p.R268C)., Conclusions: Mutations in FGFR1/FGF8/PROKR2 contributed to 7.8% of our patients with CPHD/SOD. These data suggest a significant genetic overlap between conditions affecting the development of anterior midline in the human forebrain.
- Published
- 2012
- Full Text
- View/download PDF
44. Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations.
- Author
-
Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, and Raivio T
- Subjects
- Adolescent, Adult, Genotype, Hormone Replacement Therapy, Humans, Hypogonadism therapy, Kallmann Syndrome genetics, Male, Phenotype, Young Adult, DNA Helicases genetics, DNA-Binding Proteins genetics, Hypogonadism congenital, Hypogonadism genetics, Mutation, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptors, LHRH genetics
- Abstract
Background: Congenital hypogonadotropic hypogonadism (HH) is a rare cause for delayed or absent puberty. These patients may recover from HH spontaneously in adulthood. To date, it is not possible to predict who will undergo HH reversal later in life. Herein we investigated whether Finnish patients with reversal of congenital hypogonadotropic hypogonadism (HH) have common phenotypic or genotypic features., Methods and Findings: Thirty-two male HH patients with anosmia/hyposmia (Kallmann Syndrome, KS; n = 26) or normal sense of smell (nHH; n = 6) were enrolled (age range, 18-61 yrs). The patients were clinically examined, and reversal of HH was assessed after treatment withdrawal. KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, WDR11, GNRHR, GNRH1, KISS1R, KISS1, TAC3, TACR3, and LHβ were screened for mutations. Six HH patients (2 KS, 4 nHH) were verified to have reversal of HH. In the majority of cases, reversal occurred early in adulthood (median age, 23 yrs; range, 21-39 yrs). All had spontaneous testicular growth while on testosterone replacement therapy (TRT). One nHH subject was restarted on TRT due to a decline in serum T. Two reversal variants had a same GNRHR mutation (R262Q), which was accompanied by another GNRHR mutation (R139H or del309F). In addition, both of the KS patients had a mutation in CHD7 (p.Q51X) or FGFR1 (c.91+2T>A)., Conclusions: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.
- Published
- 2012
- Full Text
- View/download PDF
45. LIN28B, LIN28A, KISS1, and KISS1R in idiopathic central precocious puberty.
- Author
-
Tommiska J, Sørensen K, Aksglaede L, Koivu R, Puhakka L, Juul A, and Raivio T
- Abstract
Background: Pubertal timing is a strongly heritable trait, but no single puberty gene has been identified. Thus, the genetic background of idiopathic central precocious puberty (ICPP) is poorly understood. Overall, the genetic modulation of pubertal onset most likely arises from the additive effect of multiple genes, but also monogenic causes of ICPP probably exist, as cases of familial ICPP have been reported. Mutations in KISS1 and KISSR, coding for kisspeptin and its receptor, involved in GnRH secretion and puberty onset, have been suggested causative for monogenic ICPP. Variation in LIN28B was associated with timing of puberty in genome-wide association (GWA) studies. LIN28B is a human ortholog of the gene that controls, through microRNAs, developmental timing in C. elegans. In addition, Lin28a transgenic mice manifest the puberty phenotypes identified in the human GWAS. Thus, both LIN28B and LIN28A may have a role in pubertal development and are good candidate genes for monogenic ICPP., Methods: Thirty girls with ICPP were included in the study. ICPP was defined by pubertal onset before 8 yrs of age, and a pubertal LH response to GnRH testing. The coding regions of LIN28B, LIN28A, KISS1, and KISS1R were sequenced. The missense change in LIN28B was also screened in 132 control subjects., Results: No rare variants were detected in KISS1 or KISS1R in the 30 subjects with ICPP. In LIN28B, one missense change, His199Arg, was found in one subject with ICPP. However, this variant was also detected in one of the 132 controls. No variation in LIN28A was found., Conclusions: We did not find any evidence that mutations in LIN28B or LIN28A would underlie ICPP. In addition, we confirmed that mutations in KISS1 and KISS1R are not a common cause for ICPP.
- Published
- 2011
- Full Text
- View/download PDF
46. Isolated cryptorchidism: no evidence for involvement of genes underlying isolated hypogonadotropic hypogonadism.
- Author
-
Laitinen EM, Tommiska J, Virtanen HE, Oehlandt H, Koivu R, Vaaralahti K, Toppari J, and Raivio T
- Subjects
- Case-Control Studies, DNA Mutational Analysis, Gastrointestinal Hormones genetics, Genetic Association Studies, Humans, Infant, Infant, Newborn, Male, Neuropeptides genetics, Polymorphism, Genetic, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptors, G-Protein-Coupled genetics, Receptors, LHRH genetics, Receptors, Peptide genetics, Receptors, Tachykinin genetics, Tachykinins genetics, Cryptorchidism genetics, Hypogonadism genetics
- Abstract
Mutations in FGFR1, GNRHR, PROK2, PROKR2, TAC3, or TACR3 underlie isolated hypogonadotropic hypogonadism (IHH) with clinically variable phenotypes, and, by causing incomplete intrauterine activation of the hypothalamic-pituitary-gonadal axis, may lead to cryptorchidism. To investigate the role of defects in these genes in the etiology of isolated cryptorchidism, we screened coding exons and exon-intron boundaries of these genes in 54 boys or men from 46 families with a history of cryptorchidism. Control subjects (200) included 120 males. None of the patients carried mutation(s) in FGFR1, PROK2, PROKR2, TAC3 or TACR3. Two of the 46 index subjects with unilateral cryptorchidism were heterozygous carriers of a single GNRHR mutation (Q106R or R262Q), also present in male controls with a similar frequency (3/120; p=0.62). No homozygous or compound heterozygous GNRHR mutations were found. In conclusion, cryptorchidism is not commonly caused by defects in genes involved in IHH., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
47. The role of gene defects underlying isolated hypogonadotropic hypogonadism in patients with constitutional delay of growth and puberty.
- Author
-
Vaaralahti K, Wehkalampi K, Tommiska J, Laitinen EM, Dunkel L, and Raivio T
- Subjects
- Case-Control Studies, DNA Mutational Analysis, Female, Finland, Genetic Predisposition to Disease, Growth Disorders physiopathology, Humans, Hypogonadism physiopathology, Male, Neurokinin B genetics, Pedigree, Phenotype, Receptor, Fibroblast Growth Factor, Type 1 genetics, Receptors, LHRH genetics, Receptors, Neurokinin-3 genetics, Risk Assessment, Risk Factors, Growth Disorders genetics, Hypogonadism genetics, Mutation, Puberty, Delayed genetics
- Abstract
Variation in FGFR1, GNRHR, TAC3, and TACR3 was evaluated in 146 Finnish subjects with constitutional delay of growth and puberty. Although one male subject carried a previously undescribed heterozygous deletion (Phe309del) in GNRHR, which segregated with delayed puberty in his family, mutations in the coding regions of FGFR1, GNRHR, TAC3, and TACR3 are not likely to underlie common constitutional delay of growth and puberty., (Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
48. Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland.
- Author
-
Laitinen EM, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L, and Raivio T
- Subjects
- Adolescent, Adult, DNA Mutational Analysis, Female, Finland epidemiology, Humans, Hypogonadism epidemiology, Hypogonadism genetics, Hypogonadism pathology, Incidence, Kallmann Syndrome genetics, Male, Middle Aged, Olfaction Disorders epidemiology, Olfaction Disorders genetics, Olfaction Disorders pathology, Pedigree, Phenotype, Young Adult, Extracellular Matrix Proteins genetics, Kallmann Syndrome epidemiology, Kallmann Syndrome pathology, Mutation, Nerve Tissue Proteins genetics, Receptor, Fibroblast Growth Factor, Type 1 genetics
- Abstract
Background: Kallmann syndrome (KS), comprised of congenital hypogonadotropic hypogonadism (HH) and anosmia, is a clinically and genetically heterogeneous disorder. Its exact incidence is currently unknown, and a mutation in one of the identified KS genes has only been found in ~30% of the patients., Methods: Herein, we investigated epidemiological, clinical, and genetic features of KS in Finland., Results: The minimal incidence estimate of KS in Finland was 1:48 000, with clear difference between males (1:30 000) and females (1:125 000) (p = 0.02). The reproductive phenotype of 30 probands (25 men; 5 women) ranged from severe HH to partial puberty. Comprehensive mutation analysis of all 7 known KS genes (KAL1, FGFR1, FGF8, PROK2, PROKR2, CHD7, and WDR11) in these 30 well-phenotyped probands revealed mutations in KAL1 (3 men) and FGFR1 (all 5 women vs. 4/25 men), but not in other genes., Conclusions: Our results suggest that Finnish KS men harbor mutations in gene(s) yet-to-be discovered with sex-dependent penetrance of the disease phenotype. In addition, some KS patients without CHD7 mutations display CHARGE-syndrome associated phenotypic features (e.g. ear or eye anomalies), possibly implying that, in addition to CHD7, there may be other genes associated with phenotypes ranging from KS to CHARGE.
- Published
- 2011
- Full Text
- View/download PDF
49. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy.
- Author
-
Götz A, Tyynismaa H, Euro L, Ellonen P, Hyötyläinen T, Ojala T, Hämäläinen RH, Tommiska J, Raivio T, Oresic M, Karikoski R, Tammela O, Simola KO, Paetau A, Tyni T, and Suomalainen A
- Subjects
- Base Pairing, Cardiomyopathy, Hypertrophic pathology, DNA Mutational Analysis, DNA, Mitochondrial genetics, Female, Humans, Infant, Infant, Newborn, Mitochondrial Diseases pathology, Pedigree, Protein Structure, Tertiary, Alanine-tRNA Ligase genetics, Cardiomyopathy, Hypertrophic genetics, Mitochondria genetics, Mitochondrial Diseases genetics, Mutation, Missense
- Abstract
Infantile cardiomyopathies are devastating fatal disorders of the neonatal period or the first year of life. Mitochondrial dysfunction is a common cause of this group of diseases, but the underlying gene defects have been characterized in only a minority of cases, because tissue specificity of the manifestation hampers functional cloning and the heterogeneity of causative factors hinders collection of informative family materials. We sequenced the exome of a patient who died at the age of 10 months of hypertrophic mitochondrial cardiomyopathy with combined cardiac respiratory chain complex I and IV deficiency. Rigorous data analysis allowed us to identify a homozygous missense mutation in AARS2, which we showed to encode the mitochondrial alanyl-tRNA synthetase (mtAlaRS). Two siblings from another family, both of whom died perinatally of hypertrophic cardiomyopathy, had the same mutation, compound heterozygous with another missense mutation. Protein structure modeling of mtAlaRS suggested that one of the mutations affected a unique tRNA recognition site in the editing domain, leading to incorrect tRNA aminoacylation, whereas the second mutation severely disturbed the catalytic function, preventing tRNA aminoacylation. We show here that mutations in AARS2 cause perinatal or infantile cardiomyopathy with near-total combined mitochondrial respiratory chain deficiency in the heart. Our results indicate that exome sequencing is a powerful tool for identifying mutations in single patients and allows recognition of the genetic background in single-gene disorders of variable clinical manifestation and tissue-specific disease. Furthermore, we show that mitochondrial disorders extend to prenatal life and are an important cause of early infantile cardiac failure., (Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
50. LIN28B in constitutional delay of growth and puberty.
- Author
-
Tommiska J, Wehkalampi K, Vaaralahti K, Laitinen EM, Raivio T, and Dunkel L
- Subjects
- Adolescent, Alleles, Child, DNA Mutational Analysis, DNA, Complementary biosynthesis, DNA, Complementary genetics, Exons genetics, Female, Genome-Wide Association Study, Humans, Leukocytes metabolism, Male, MicroRNAs genetics, Mutation genetics, Mutation physiology, Phenotype, Puberty genetics, Puberty physiology, RNA-Binding Proteins, Reverse Transcriptase Polymerase Chain Reaction, DNA-Binding Proteins genetics, Growth genetics, Puberty, Delayed genetics
- Abstract
Background: Recently variation in LIN28B, a human ortholog of the gene-regulating processing of micro-RNAs (miRNAs) controlling the timing of major developmental events in the nematode Caenorhabditis elegans, was reported to be associated with timing of puberty in humans. In C. elegans, a gain-of-function allele of lin-28 causes a retarded phenotype., Objective: The objective of the study was to evaluate the variation in the LIN28B gene in 145 subjects with constitutional delay of growth and puberty (CDGP)., Patients and Methods: For this study, 115 males and 30 females with CDGP were included. CDGP was defined by Tanner genital or breast stage II and pubertal growth spurt taking place 2 SD later than average. The four coding exons (exons 1-4) and exon-intron boundaries, as well as the fragment of 3' untranslated region containing miRNA recognition elements A and B, of LIN28B were PCR amplified from genomic DNA obtained from peripheral blood leukocytes of the subjects and bidirectionally sequenced., Results: No variation in the coding region of LIN28B in the 145 subjects with CDGP was found. However, 16 of 145 subjects carried a 2-nucleotide deletion immediately 5' from miRNA recognition element A. These patients did not differ in phenotypic features as compared with noncarriers, and this variant was present in 100 controls with the same frequency., Conclusions: Our results show that mutations in the coding region or 3' untranslated region miRNA recognition elements A and B of LIN28B do not underlie CDGP. Lack of any variation in the coding region of the gene suggests that LIN28B in developmental timing is so crucial that any changes in the conserved protein would probably be lethal.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.